Revolution Medicines, Inc. (RVMDW) Free cash flow 2018–2025
Revolution Medicines, Inc. (RVMDW) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$913.7MFY2025 · since FY2018: -$286,000 → -$913.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$913.7M | -60.9% |
| FY2024 | -$567.7M | -58.5% |
| FY2023 | -$358.3M | -52.3% |
| FY2022 | -$235.2M | -53.0% |
| FY2021 | -$153.7M | -49.2% |
| FY2020 | -$103.0M | -97.3% |
| FY2019 | -$52.2M | -18153.5% |
| FY2018 | -$286,000 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RVMDW financial trends
RVMDW RevenueRVMDW Net incomeRVMDW Net marginRVMDW Gross profitRVMDW Gross marginRVMDW Operating incomeRVMDW Operating marginRVMDW Operating cash flowRVMDW Capital expendituresRVMDW Return on equityRVMDW Stock buybacksRVMDW Dividends paidRVMDW Total assetsRVMDW Total liabilitiesRVMDW Shareholders’ equityRVMDW overview →